ArticleEuropean journal of neurology2021

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.

Gabriel Bsteh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.